FMC Corp vs InMode Ltd — how do they compare? FMC Corp trades at $11.56 (market cap $1.36B), while InMode Ltd trades at $15.43 (market cap $878.31M). The key difference: FMC Corp is the larger of the two by market cap, and FMC Corp pays a 2.95% dividend while InMode Ltd pays none. Which is the better fit depends on your goals.
| FMC | INMD | |
|---|---|---|
Market Cap | $1.36B | $878.31M |
Sector | Basic Materials | Technology |
52-Week High | $43.90 | $16.62 |
52-Week Low | $10.72 | $12.76 |
Enterprise Value | $5.50B | $345.98M |
Dividend Yield | 2.95% | — |
Signals from Pluang's Aura AI — not financial advice
FMC Corporation (FMC) trades at $10.72, down 1.74% on the day, reflecting ongoing challenges despite recent strategic moves. The stock shows a bearish technical trend with oversold RSI signals, while fundamentals reveal significant pressure with a net income margin of -72.93% and negative ROE of -80.78% for 2025. Recent developments include a $400 million minority investment from Tessenderlo Group and regulatory submission for new herbicide rimisoxafen, providing some operational support amid financial restructuring.
The outlook remains cautious with analyst consensus leaning neutral (50% Hold) despite a $16 price target suggesting 49% upside. Key risks include persistent revenue declines, high debt levels, and negative cash flow from operations. Investment opportunity exists if new product approvals and debt reduction efforts successfully stabilize profitability, but current financial metrics indicate substantial execution risk near term.
INMD trades at $15.36, up 2.92% today, with a bullish technical signal from moving averages. The company maintains strong profitability with a 77.84% gross margin and 23.27% net margin, while valuation ratios appear attractive with a P/E of 11.32. Recent news includes an unsolicited acquisition offer of $16.75 per share from Steel Partners and Q2 2026 revenue guidance of $95.2M-$95.4M.
The stock presents a mixed outlook: upside exists from potential acquisition interest and solid fundamentals, but risks include a recent earnings miss, ongoing securities fraud investigations, and overbought technical indicators. Analyst consensus is divided with a $16.50 price target suggesting moderate upside from current levels.
Trailing returns across standard periods
Latest headlines on both assets
FMC is a pure-play crop chemical company. The company has diversified its sales to create a balanced crop chemical portfolio across geographies and crop exposure. Through acquisitions, FMC is now one of the five largest patented crop chemical companies and will continue to develop new products, with a focus on biologicals, through its research and development pipeline.
Read more on FMC →InMode provides innovative medical technologies for minimally invasive surgical procedures. Its platforms use radiofrequency (RF) energy for aesthetic treatments like body contouring and skin tightening.
Read more on INMD →